This AI Analysis Found GLP-1 Side Effects Missing From Clinical Trials
AI, Reddit threads, GLP-1s, and the research journal Nature—I can’t say I ever expected to see those words in the same sentence. And yet, here we are.
A new study1 pulled data from hundreds of thousands of Reddit posts, using AI to analyze how people are actually talking about their experiences on GLP-1 medications in real time. Not in a clinical setting, not through structured questionnaires, but in the messy, unfiltered way people describe what’s happening in their bodies when no one is prompting them.
This study doesn’t rewrite what we know about GLP-1 medications. But it does expand the conversation, pointing to a growing gap between controlled research and lived experience, and raising the question of what we might be missing in between.
Using AI to analyze real-world GLP-1 experiences
Researchers analyzed more than 400,000 Reddit posts written between 2019 and 2025, focusing on discussions around GLP-1 receptor agonists like semaglutide and tirzepatide. Out of that massive dataset, over 67,000 users identified themselves as taking one of these medications.
Instead of relying on pre-defined symptom checklists, the team used AI to interpret how people naturally describe their experiences. That matters because clinical trials tend to capture side effects in structured ways, while real-world users often describe symptoms in less clinical, more nuanced language.
About 43.5% of users reported at least one side effect. Many of these were expected. Gastrointestinal symptoms like nausea, vomiting, constipation, and diarrhea showed up frequently, which aligns with what’s already documented in clinical trials.
But there was more to it than that.
The overlooked side effects showing up in real life
Beyond the known digestive issues, a few patterns stood out that aren’t as clearly represented in current drug labeling or trial data.
One of them was fatigue. It showed up as one of the most commonly discussed symptoms, even though it hasn’t been emphasized to the same degree in clinical research. For some users, this wasn’t just feeling a little tired. It was persistent, noticeable, and disruptive to daily routines.
Another category was reproductive changes, including irregular menstrual cycles and unexpected bleeding. Nearly 4% of users who reported side effects mentioned some form of menstrual disruption. That number may actually be an underestimate, given the platform’s user demographics. Reddit tends to skew more male, which means these experiences may be underrepresented in the data to begin with.
There were also frequent mentions of temperature sensitivity. People described feeling unusually cold, experiencing chills, or having hot flashes that didn’t seem tied to external conditions.
None of this proves the medications are directly causing these symptoms. But the patterns are consistent enough to raise questions, especially when you look a little closer at how these drugs work in the body.
Why these side effects might be happening in the first place
GLP-1 medications don’t just affect appetite and blood sugar. They also act on the hypothalamus, a small but powerful region of the brain that helps regulate hormones, body temperature, hunger, and overall energy balance. It’s essentially a command center for many of the processes people are describing in these posts.
Take fatigue, for example. On paper, GLP-1s can improve metabolic health, which you might expect to support energy levels over time. But in the short term, several things could be at play. Reduced calorie intake, shifts in blood sugar regulation, and changes in how the body processes nutrients can all influence how energized someone feels day to day. For some people, that adjustment period may show up as lingering fatigue that isn’t always emphasized in clinical conversations.
The same goes for reproductive changes. The hypothalamus plays a key role in signaling pathways that regulate the menstrual cycle. When energy balance shifts, whether from weight loss, appetite changes, or metabolic adjustments, it can influence those hormonal signals. This is something that’s been observed in other contexts too, like intense training or under-fueling, where the body perceives a change in available energy and adapts accordingly.
Temperature regulation is also closely tied to this system. The hypothalamus helps maintain internal body temperature, so even subtle shifts in how it’s functioning could theoretically influence sensations like feeling unusually cold, experiencing chills, or having hot flashes. These aren’t random symptoms; they’re connected to a system that’s actively being influenced by the medication.
None of this confirms a direct cause-and-effect relationship. But it does offer a framework for understanding why these experiences might be showing up in real-world use, even if they haven’t been fully captured in clinical trial data yet.
The takeaway
What makes this study particularly interesting isn’t just what it found, but how it found it. Using AI to analyze large-scale, real-world conversations opens up a new way of understanding how treatments actually impact people’s lives. It brings in a layer of nuance that’s hard to capture in clinical settings, where the focus is often on clear, measurable outcomes rather than the day-to-day experience of being on a medication.
We’re moving toward a model where clinical data and lived experience can exist side by side. One tells us what should happen. The other shows us what does happen. That doesn’t mean one is more valid than the other. But studies like this highlight how much context can be added when we start paying closer attention to patient-reported experiences at scale.
And when those two perspectives don’t fully line up, that gap can be just as informative as the data itself. It can point researchers toward new questions, help clinicians have more informed conversations, and ultimately give patients a more complete picture of what to expect.